Imaging of immune responses and tumor cell invasion in glioma models
Glioblastoma is a malignant brain tumor with poor survival. Imaging in glioblastoma, mainly performed by magnetic resonance imaging, is restricted to morphological information (tumor size, perifocal edema). Immunotherapies aim to elicit anti-tumor immune responses but monitoring treatment effects beyond the macroscopic tumor size remains difficult. Visualizing immune responses by direct tracking of effector cells could facilitate preclinical therapy development and allow treatment monitoring and patient stratification.